Monteiro · Nutrients 2026 · narrative review of randomized controlled trials · n=22 studies

Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.

Cited 14 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review synthesizing mechanisms and 22 clinical trials without formal systematic review methodology

PubMed 41683196 · doi:10.3390/nu18030372 · record verified 2026-08-29

What was done

This narrative review examined the structural properties of major prebiotics, including inulin, fructooligosaccharides, and galactooligosaccharides, in relation to their fermentation mechanisms. To assess clinical efficacy, the authors evaluated 22 randomized controlled trials published over the past decade that investigated International Scientific Association for Probiotics and Prebiotics (ISAPP)-recognized prebiotics as sole interventions in human populations.

What was found

The abstract reports no numerical effect sizes or statistical values. Prebiotic supplementation consistently increased the abundance of Bifidobacterium and Lactobacillus species and elevated short-chain fatty acid production. These changes correlated with improvements in stool frequency, stool consistency, intestinal barrier function, and immune response modulation across healthy cohorts, pediatric and elderly populations, and individuals with constipation, metabolic syndrome, or antibiotic-associated dysbiosis. Marked inter-individual response variability and heterogeneity in prebiotic type, dosage, and duration were noted.

Why it matters

This review links the structural chemistry of prebiotics directly to biological fermentation pathways and clinical gastrointestinal outcomes across diverse groups. It underscores the need for standardizing intervention protocols and transitioning toward personalized prebiotic strategies.

Limits

The abstract provides no numerical data, pooled effect estimates, or total human sample size. High heterogeneity existed across prebiotic types, dosages, and treatment durations in the evaluated trials. As a narrative review rather than a systematic review or meta-analysis, potential study selection bias and individual trial risk of bias cannot be ruled out.

Cited by